Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H.
Furumoto H, et al. Among authors: fukushima h.
Cancers (Basel). 2022 Aug 22;14(16):4042. doi: 10.3390/cancers14164042.
Cancers (Basel). 2022.
PMID: 36011036
Free PMC article.